Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

BACKGROUND: Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1 nCov-19, AstraZeneca). More data were needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Greinacher, Andreas, Thiele, Thomas, Warkentin, Theodore E., Weisser, Karin, Kyrle, Paul A., Eichinger, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095372/
https://www.ncbi.nlm.nih.gov/pubmed/33835769
http://dx.doi.org/10.1056/NEJMoa2104840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095372/
https://www.ncbi.nlm.nih.gov/pubmed/33835769
http://dx.doi.org/10.1056/NEJMoa2104840

Ejemplares similares